Navidea Biopharmaceuticals, Inc. With a strong dedication to improving patient care, Navidea focuses on developing innovative immunodiagnostic agents and immunotherapeutics to identify the sites and pathways of undetected diseases. By leveraging the power of precision diagnostics, Navidea aims to enhance diagnostic accuracy, clinical decision-making, targeted treatment, and ultimately, patient outcomes.

From cancer and autoimmune diseases to infectious and inflammatory conditions, Navidea's immuno-targeted products offer hope to patients and their families, as well as physicians and care providers. By delivering cutting-edge diagnostic agents and therapies, Navidea is committed to improving the lives of individuals faced with serious illnesses. Driven by its innovative Manocept™ platform, Navidea is dedicated to continuous growth and superior performance.

Furthermore, the company values its employees and fosters a development environment where breakthrough products can thrive, making a direct impact on the patients they serve. As a leader in the field, Navidea has attracted top-tier talent to its Management Team and Board of Directors, ensuring excellence in research, development, and commercialization of precision diagnostic and radiopharmaceutical imaging agents